Cite
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
MLA
Markus Otto, et al. “Advantages and Disadvantages of the Use of the CSF Amyloid β (Aβ) 42/40 Ratio in the Diagnosis of Alzheimer’s Disease.” Alzheimer’s Research & Therapy, vol. 11, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c709a9e5df0ee5db59fbd9582c6ab2b&authtype=sso&custid=ns315887.
APA
Markus Otto, Henrik Zetterberg, Piotr Lewczuk, Oskar Hansson, & Sylvain Lehmann. (2019). Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease. Alzheimer’s Research & Therapy, 11.
Chicago
Markus Otto, Henrik Zetterberg, Piotr Lewczuk, Oskar Hansson, and Sylvain Lehmann. 2019. “Advantages and Disadvantages of the Use of the CSF Amyloid β (Aβ) 42/40 Ratio in the Diagnosis of Alzheimer’s Disease.” Alzheimer’s Research & Therapy 11 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c709a9e5df0ee5db59fbd9582c6ab2b&authtype=sso&custid=ns315887.